Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
07/04/2012 | CN101491536B Therapeutically useful synthetic oligonucleotides |
07/04/2012 | CN101484453B Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics |
07/04/2012 | CN101484167B The use of derviate of pyridone for preventing and treating radioactive injury of lungs |
07/04/2012 | CN101484143B Pharmaceutical composition containing a tetrahydrofolic acid |
07/04/2012 | CN101480394B Anti-tumor pharmaceutical composition |
07/04/2012 | CN101475574B Camptothecin derivative, and preparation and use thereof |
07/04/2012 | CN101475458B Mitissimol with antineoplastic activity, preparation and use thereof |
07/04/2012 | CN101474156B Vitamin C precursor liposome and preparation method thereof |
07/04/2012 | CN101468950B Novel compound separated from immature exocarp of Juglans mandshurica Maxim, and preparation and use thereof |
07/04/2012 | CN101468050B External use medicament for treating viral keratitis and preparation method thereof |
07/04/2012 | CN101463065B Marsdenia tenacissima extract |
07/04/2012 | CN101456797B Walnut powder with anticancer activity as well as preparation method and use thereof |
07/04/2012 | CN101454289B Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments |
07/04/2012 | CN101450914B Novel benzoic acid derivatives |
07/04/2012 | CN101448812B Inhibitors of human immunodeficiency virus replication |
07/04/2012 | CN101444521B Pharmaceutical preparation containing alendronate sodium and cholecalciferol-cholesterol |
07/04/2012 | CN101443336B Cyclopropyl fused indolobenzazepine HVC ns5b inhibitors |
07/04/2012 | CN101439135B Chinese medicine granule containing extract of grassleaved sweetflag rhizome and preparation method thereof |
07/04/2012 | CN101439042B Anti-tumor use of isoamylene flavonoid glycoside |
07/04/2012 | CN101434525B 4-(4-hydroxy3-methoxybenzene methyl) curcumin and use thereof in preparing anti-tumor medicament |
07/04/2012 | CN101418294B Antisense nucleic acid of methicillin-resistant staphylococcus aureus resistance gene mecA |
07/04/2012 | CN101416972B External medicine capable of preventing and treating cardiovascular disease and preparation method thereof |
07/04/2012 | CN101410114B A3 adenosine receptor allosteric modulators |
07/04/2012 | CN101405016B Lypolysis promoter |
07/04/2012 | CN101402573B Bihydroxyl-2-acyl benzene acetic acid ester, producing method and uses thereof |
07/04/2012 | CN101402565B Halogenated 2-(a-hydroxyl pentyl) benzoate, production method and uses thereof |
07/04/2012 | CN101401885B Liquid medicine for removing miliaria and preparation method thereof |
07/04/2012 | CN101396397B Medicine composition for preventing the birth defect and improving the memory |
07/04/2012 | CN101390989B Traditional Chinese medicine preparation for treating recurrent oral ulcer |
07/04/2012 | CN101389603B Crystalline form of the arginine salt of perindopril, process for preparing it, and pharmaceutical compositions comprising it |
07/04/2012 | CN101381418B Sterculia seed single polysaccharide SPA, preparation method and application thereof |
07/04/2012 | CN101381360B Grafts of plant polyphenol and weathered coal humic acid degradation product and grafting method |
07/04/2012 | CN101375906B Pharmaceutical combination for preventing birth-defect and improving memory |
07/04/2012 | CN101375896B Pharmaceutical combination for preventing birth-defect and improving memory |
07/04/2012 | CN101375845B Podophyllotoxin external-use formulation prescription for treating pointed condyloma and herpes genitalis, dosage form series and preparation method |
07/04/2012 | CN101375834B Solid dispersion of Ailamode and preparation method thereof and medicament application |
07/04/2012 | CN101374512B Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
07/04/2012 | CN101370496B Novel thiophene derivatives as S1P1/EDG1 receptor agonists |
07/04/2012 | CN101367815B Six-membered ring methanamide substituted sulfhydryl pyrrolidine carbpenem compound |
07/04/2012 | CN101366873B Medicament composition for preventing birth defect and improving memory |
07/04/2012 | CN101366872B Medicament composition for preventing birth defect and improving memory |
07/04/2012 | CN101366864B Medicament composition for preventing birth defect and improving memory |
07/04/2012 | CN101366863B Medicament composition for preventing birth defect and improving memory |
07/04/2012 | CN101366841B Medicament composition for preventing birth defection and improving memory |
07/04/2012 | CN101366823B Medicament composition for preventing birth defect and improving memory |
07/04/2012 | CN101366788B Medicament composition for preventing birth defect and improving memory |
07/04/2012 | CN101366783B Medicament composition for preventing birth defection and improving memory |
07/04/2012 | CN101366777B Medicament composition for preventing birth defection and improving memory |
07/04/2012 | CN101366776B Medicament composition for preventing birth defection and improving memory |
07/04/2012 | CN101366774B Medicament composition for preventing birth defection and improving memory |
07/04/2012 | CN101366750B Medicament composition for preventing birth defect and improving memory |
07/04/2012 | CN101366746B Pharmaceutical combination for preventing birth defect and improving anamnesis |
07/04/2012 | CN101365671B Isohumulone compound clathrate and composition containing the same |
07/04/2012 | CN101357939B Protein conjugate and pharmaceutical compositions thereof |
07/04/2012 | CN101343302B Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives |
07/04/2012 | CN101342286B Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny |
07/04/2012 | CN101333237B Oligonucleotide with breast carcinoma treating function |
07/04/2012 | CN101317850B Sucrose absorption inhibitor |
07/04/2012 | CN101307044B Two crystallographic form of pinocembrin compounds, preparation method and applications for treating diseases |
07/04/2012 | CN101306013B Use of modified polysaccharide rich in galactose in preparing medicine for preventing the colitis cancer |
07/04/2012 | CN101296912B Theramutein modulators |
07/04/2012 | CN101296693B 持久力提高剂 Endurance enhancing agent |
07/04/2012 | CN101291670B Carbazole derivatives as functional 5-HT6 ligands |
07/04/2012 | CN101274006B Pharmaceutical combination of prepotency for preventing birth-defect and improving memory |
07/04/2012 | CN101274002B Pharmaceutical combination of prepotency for preventing birth-defect and improving memory |
07/04/2012 | CN101259120B Methods of inducing terminal differentiation |
07/04/2012 | CN101248064B Nitrocatechol derivatives as COMT inhibitors |
07/04/2012 | CN101238125B Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
07/04/2012 | CN101230096B Peptide derived from hepatitis C virus |
07/04/2012 | CN101229254B Chinese traditional medicine preparation for treating cerebral apoplexy without sequelae |
07/04/2012 | CN101209344B Application of hyperosmotic fluid composition in preparing medicament for improving wound healing |
07/04/2012 | CN101208437B Biosensors for detecting macromolecules and other analytes |
07/04/2012 | CN101208084B Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity |
07/04/2012 | CN101208079B Methods of suppressing UV light-induced skin carcinogenesis |
07/04/2012 | CN101194920B Lithospermum and application of its active ingredient in preparing medicament for treating tumour stem cell |
07/04/2012 | CN101177445B Novel bufadienolide compound as well as preparation method and uses thereof |
07/04/2012 | CN101141963B Pellet-type controlled-release preparation for combating vertigo |
07/04/2012 | CN101141962B Tablet-type controlled-release preparation for combating vertigo |
07/04/2012 | CN101137357B Antimicrobial compositions comprising esters of hydroxycarboxylic acids |
07/04/2012 | CN101129188B Legalon mastication patch and method of preparing the same |
07/04/2012 | CN101128197B Preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion |
07/04/2012 | CN101115763B Novel polyphenol glycoside derived from acerola |
07/04/2012 | CN101106987B Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
07/04/2012 | CN101090978B Process for the synthesis of cefaclor |
07/04/2012 | CN101088522B Chinese medicine composition containing red sage, notoginseng and musk or muskone and its prepn |
07/04/2012 | CN101085064B Composition containing radix paeoniae rubrathe for treating cardiovascular diseases and its preparation |
07/04/2012 | CN101023950B Allopurinol sodium sterilzed powder for injection and preparing method |
07/03/2012 | US8212079 Cocrystallization |
07/03/2012 | US8212057 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
07/03/2012 | US8212052 Dual-acting benzoimidazole antihypertensive agents |
07/03/2012 | US8212051 Process for the preparation of pure irbesartan |
07/03/2012 | US8212046 Process for producing crystal |
07/03/2012 | US8212045 Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus |
07/03/2012 | US8212041 Fused heterocyclic derivatives and methods of use |
07/03/2012 | US8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
07/03/2012 | US8212039 Phosphonic acid compounds as inhibitors of serine proteases |
07/03/2012 | US8212032 sEH inhibitors and their use |
07/03/2012 | US8212029 Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6H-benzofuro [3a, 3, 2-ef] [2] benzazepine, and the derivatives thereof |
07/03/2012 | US8212024 crystallizing Ceftiofur sodium directly from the reaction mass; obviates the use of amine, sodium salt of weak acid like sodium 2-ethylhexonate and membrane filtration in Ceftiofur sodium synthesis |
07/03/2012 | US8211947 Composition and method for treating and preventing musculoskeletal and connective tissue disorders |